Relevium_LOGO_200.jpg
Relevium Announces Shareholder Townhall and Conference Call
June 15, 2021 10:11 ET | Relevium Technologies Inc
MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...
Relevium_LOGO_200.jpg
Relevium Announces Maturity of the Outstanding Convertible Debenture Notes and Begins Negotiations With Debenture Holders
June 10, 2021 08:11 ET | Relevium Technologies Inc
MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announces today the maturity of its...
Relevium_LOGO_200.jpg
Relevium Announces the Appointment of Dr. Wolfgang Renz as Chief Scientific Officer for Biocannabix Health Corporation
May 20, 2021 02:00 ET | Relevium Technologies Inc
MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium_LOGO_200.jpg
Relevium Provides Update on the Exclusive Supply of Medical Examination Gloves
May 05, 2021 09:47 ET | Relevium Technologies Inc
MONTREAL, May 05, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), whose primary mandate is to focus on...
Relevium_LOGO_200.jpg
Biocannabix Enters Into LOI With IAM Health GmbH
April 29, 2021 09:12 ET | Relevium Technologies Inc
MONTREAL, April 29, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), and its’ wholly-owned subsidiary, Biocannabix...
Relevium_LOGO_200.jpg
Relevium Secures North American Exclusivity for Medical Examination Gloves, with First Shipment to Arrive in Los Angeles by Mid April
March 11, 2021 13:59 ET | Relevium Technologies Inc
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the company has...
Relevium_LOGO_200.jpg
Relevium Announces Investor Relations Conference Call
February 04, 2021 16:48 ET | Relevium Technologies Inc
MONTREAL, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to invite all shareholders,...
Relevium_LOGO_200.jpg
Relevium Reports Interim First Quarter Results for the Three-Month Period Ended September 30, 2020
January 25, 2021 09:42 ET | Relevium Technologies Inc
MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the...
Relevium_LOGO_200.jpg
Relevium Reports Fiscal Year Ended June 30, 2020 Results
January 20, 2021 07:11 ET | Relevium Technologies Inc
MONTREAL, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to report the completion of the...
Relevium_LOGO_200.jpg
Relevium Issues Corporate Update on MCTO and Filing of Financial Statements
January 06, 2021 17:58 ET | Relevium Technologies Inc
MONTREAL, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”) announces an update on its ongoing disclosure...